-
Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rateSardu C, Paolisso P, Sacra C et al. -
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFMartinez FA, Serenelli M, Nicolau JC et al.
-
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled StudyAH Larsen, H Wiggers, Niels Jessen et al.
-
Titration of Medical Therapy for Heart Failure With Reduced Ejection FractionSJ Greene, GC Fonarow, AD DeVore et al.
-
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionMcMurray JJV, SD Solomon, DAPA-HF Committees and Investigators.
-
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart FailureDB Mark, PA Cowper, KJ Anstrom et al.
-
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)DP Leong, JJV McMurray, PG Joseph et al.
-
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Pieske B Tschöpe C, de Boer RA et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
